Challenges and solutions for the benefit assessment of tumor-agnostic therapies in Germany.
Juliane SchillerHelene EckhardtSarah SchmitterValerie A AlberTanja Rombey
Published in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
A range of possible solutions, that can help to meet the identified challenges in Germany, have been found. Future research should investigate the acceptance and feasibility of these solutions.